Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Polypharmacy highlights the problem with conventional medicine

Harriet Pike’s recent article in The Pharmaceutical Journal‘Deprescribing: the fightback against polypharmacy has begun’, points to a clear problem relating to conventional medicine. The reductionist approach associated with this type of medicine lends itself to polypharmacy. Initially, a doctor will monitor a patient’s progress through life by controlling blood pressure, cholesterol, sugar and so on. Unfortunately, this control is generally drug managed.

By the time this patient reaches the age of around 60 years, he can experience other symptoms, such as those relating to his digestive or skeletal system. Again, more drug intervention is involved, resulting in a total daily intake of between 6 and 12 different drugs. This happens at a time of life when the body is least able to assimilate or eliminate drugs; i.e. the liver and kidneys are no longer working at optimal efficiency. Given time, each drug will produce pathology in the same way that smoking tobacco will initially produce functional change, but after decades will produce tissue change in the arteries. This insidious development will not always be recognised by the doctor who, instead of abandoning this drug, will often attempt to save the situation by administering another counteracting drug.

Needless to say, the one person who suffers in this situation is the patient. We now need a vitalistic and holistic approach to our health problems, rather than a drug disease superimposed on top of a natural disease.

Alexander Black, homeopath, Lanarkshire

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205851

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.